Skip to content
drillr.ai
Sign up

LH

Labcorp Holdings, Inc.

NYSE · Healthcare · Medical - Equipment & Services · US

$318.83
+0.28%
Ask drillr

  • Oct 15, 2026, 11:30 UTC

    LABCORP HOLDINGS INC. entered into an agreement with OPKO HEALTH, INC. to acquire select assets of BioReference Health.

    Source:

  • Sep 30, 2026, 12:30 UTC

    Labcorp Holdings Inc. announced it will report its third quarter 2026 financial results on October 28, 2026.

    Source:

  • Sep 28, 2026, 21:45 UTC

    Labcorp agreed to pay Alaska $26,010 and strengthen vendor oversight to settle a multi-state investigation into the 2019 American Medical Collection Agency data breach that affected 82,958 Alaska residents.

    Source:

  • Sep 24, 2026, 22:30 UTC

    Labcorp agreed to pay $2,287,455 to 44 states to settle claims over a 2018-2019 data breach involving its debt collector American Medical Collection Agency that exposed personal information of over 27.5 million people.

    Source:

  • Sep 24, 2026, 21:30 UTC

    Labcorp agreed to a separate $35 million settlement in an ongoing class-action lawsuit involving other American Medical Collection Agency clients.

    Source:

  • Sep 24, 2026, 21:30 UTC

    Labcorp agreed to a $2,287,455 multistate settlement with 45 attorneys general, including North Carolina Attorney General Jeff Jackson, over a 2019 data breach involving vendor American Medical Collection Agency.

    Source:

  • Sep 24, 2026, 19:45 UTC

    New York Attorney General Letitia James and a bipartisan coalition of 43 other attorneys general secured a $2.3 million settlement and data-security reforms from Laboratory Corporation of America (Labcorp) over a 2019 data breach involving its debt collector American Medical Collection Agency.

    Source:

  • Sep 10, 2026, 17:40 UTC

    Labcorp Holdings presented a growth strategy at its 2026 Investor Day, betting on AI and specialty testing to drive growth through 2029.

    Source:

  • Sep 10, 2026, 11:00 UTC

    Labcorp reaffirmed its full-year 2026 guidance and provided a long-term outlook through 2029 at its 2026 Investor Day in Burlington, North Carolina.

    Source:

  • Sep 8, 2026, 13:42 UTC

    Labcorp acquires MLM Medical Labs.

    Source:

  • Sep 4, 2026, 23:59 UTC

    Labcorp agreed to a class action settlement over allegations it violated wiretapping laws by using third-party tracking technologies to intercept user search queries on its website.

    Source:

  • Sep 3, 2026, 17:59 UTC

    Ultrahuman raised $70 million in a funding round led by Qualcomm Ventures, with participation from Labcorp, Alpha Wave, Blume Ventures, Nexus Venture Partners, Alteria and other investors.

    Source:

  • Aug 24, 2026, 11:02 UTC

    Labcorp announced it will offer the Elecsys pTau-217 blood test, the first FDA-cleared single-biomarker blood test to detect Alzheimer's disease pathology, following FDA clearance.

    Source:

  • Aug 18, 2026, 07:43 UTC

    Labcorp Holdings Inc. shares reached a new 52-week high of $326.89 on Tuesday, trading at $323.18 with a volume of 786,484 shares.

    Source:

  • Aug 14, 2026, 00:00 UTC

    Brian J. Caveney was promoted to Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer of Labcorp Holdings, effective September 1, 2026.

  • Aug 14, 2026, 00:00 UTC

    Megan D. Bailey resigned as Executive Vice President and President, Central Laboratories and International of Labcorp Holdings, effective September 4, 2026.

  • Aug 10, 2026, 11:00 UTC

    The U.S. Food and Drug Administration approved Labcorp's PGDx elio tissue complete CDx as a companion diagnostic to identify advanced melanoma patients with certain BRAF variants eligible for targeted therapies.

    Source:

  • Jul 30, 2026, 10:50 UTC

    Labcorp reported its financial results for the second quarter of 2026, with revenue of $3.73 billion and diluted EPS of $3.64, and raised its full-year 2026 guidance.

    Source: